Recognised for Team Execution, Scientific Strength, and Commercial Potential Warsaw, Poland – Viridian Seeds is proud to announce that it has been awarded the “BestProject Team” prize at the EIT Food Seedbed Incubator Meeting in Warsaw, a flagshipEuropean programme supporting high-potential agri-food and agri-biotech ventures. The award recognises Viridian Seeds’ ability to combine deep scientific…
View article: https://www.basf.com/gb/en/media/featured-articles/News/innov-collab-day-24
View article: https://www.niab.com/news-views/news/news-new-feasibility-study-domestic-chickpea-production
The UK Innovation Corridor has profiled Viridian Seeds: Viridian Seeds is a high growth company which is potentially changing the way we grow and think about food. Growing a business needs more than a good idea – that’s just the start. Read the full article at The UK Innovation Corridor
Viridian Seeds mission is to save the planet by creating Super-legumes. It is commercialising next-generation sustainable protein crops with novel traits to increase yield and reduce biotic and abiotic stress tolerances, while increasing protein and nutritional content for climate change mitigation, resilience, and food security which it calls Super Legumes. Read more at Gubba News
Illumina has invested in six genomics start-ups for the fifth global funding cycle of its Illumina Accelerator in the San Francisco Bay area and in Cambridge, via the DNA sequencing and array-based technologies company’s Granta Park base. Read more at the Cambridge Independent
Agricultural biotech company Viridian Seeds Inc, which has operations in Cambridge UK, Galway in Ireland and Delaware in the US is one of only two UK ventures out of six global startups selected for the latest Illumina Accelerator programme. Read the Business Weekly article
Viridian Seeds was one of six start-ups chosen for the Illumina Accelerator. It will receive support for its mission to create sustainable ‘super-legumes’…. Read the Silicon Republic article
Illumina Accelerator Invests in the Fifth Global Funding Cycle of Startups Advancing Breakthrough Therapeutics, Diagnostics, Women’s Health, and Sustainable Agriculture Applications. Read more in the Illumina press release